Cargando…

Intervention against hypertension in the next generation programmed by developmental hypoxia

Evidence derived from human clinical studies and experimental animal models shows a causal relationship between adverse pregnancy and increased cardiovascular disease in the adult offspring. However, translational studies isolating mechanisms to design intervention are lacking. Sheep and humans shar...

Descripción completa

Detalles Bibliográficos
Autores principales: Brain, Kirsty L., Allison, Beth J., Niu, Youguo, Cross, Christine M., Itani, Nozomi, Kane, Andrew D., Herrera, Emilio A., Skeffington, Katie L., Botting, Kimberley J., Giussani, Dino A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6342530/
https://www.ncbi.nlm.nih.gov/pubmed/30668572
http://dx.doi.org/10.1371/journal.pbio.2006552
_version_ 1783389141774368768
author Brain, Kirsty L.
Allison, Beth J.
Niu, Youguo
Cross, Christine M.
Itani, Nozomi
Kane, Andrew D.
Herrera, Emilio A.
Skeffington, Katie L.
Botting, Kimberley J.
Giussani, Dino A.
author_facet Brain, Kirsty L.
Allison, Beth J.
Niu, Youguo
Cross, Christine M.
Itani, Nozomi
Kane, Andrew D.
Herrera, Emilio A.
Skeffington, Katie L.
Botting, Kimberley J.
Giussani, Dino A.
author_sort Brain, Kirsty L.
collection PubMed
description Evidence derived from human clinical studies and experimental animal models shows a causal relationship between adverse pregnancy and increased cardiovascular disease in the adult offspring. However, translational studies isolating mechanisms to design intervention are lacking. Sheep and humans share similar precocial developmental milestones in cardiovascular anatomy and physiology. We tested the hypothesis in sheep that maternal treatment with antioxidants protects against fetal growth restriction and programmed hypertension in adulthood in gestation complicated by chronic fetal hypoxia, the most common adverse consequence in human pregnancy. Using bespoke isobaric chambers, chronically catheterized sheep carrying singletons underwent normoxia or hypoxia (10% oxygen [O(2)]) ± vitamin C treatment (maternal 200 mg.kg(−1) IV daily) for the last third of gestation. In one cohort, the maternal arterial blood gas status, the value at which 50% of the maternal hemoglobin is saturated with oxygen (P(50)), nitric oxide (NO) bioavailability, oxidative stress, and antioxidant capacity were determined. In another, naturally delivered offspring were raised under normoxia until early adulthood (9 months). Lambs were chronically instrumented and cardiovascular function tested in vivo. Following euthanasia, femoral arterial segments were isolated and endothelial function determined by wire myography. Hypoxic pregnancy induced fetal growth restriction and fetal oxidative stress. At adulthood, it programmed hypertension by enhancing vasoconstrictor reactivity and impairing NO-independent endothelial function. Maternal vitamin C in hypoxic pregnancy improved transplacental oxygenation and enhanced fetal antioxidant capacity while increasing NO bioavailability, offsetting constrictor hyper-reactivity and replenishing endothelial function in the adult offspring. These discoveries provide novel insight into mechanisms and interventions against fetal growth restriction and adult-onset programmed hypertension in an animal model of complicated pregnancy in a species of similar temporal developmental milestones to humans.
format Online
Article
Text
id pubmed-6342530
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-63425302019-02-01 Intervention against hypertension in the next generation programmed by developmental hypoxia Brain, Kirsty L. Allison, Beth J. Niu, Youguo Cross, Christine M. Itani, Nozomi Kane, Andrew D. Herrera, Emilio A. Skeffington, Katie L. Botting, Kimberley J. Giussani, Dino A. PLoS Biol Research Article Evidence derived from human clinical studies and experimental animal models shows a causal relationship between adverse pregnancy and increased cardiovascular disease in the adult offspring. However, translational studies isolating mechanisms to design intervention are lacking. Sheep and humans share similar precocial developmental milestones in cardiovascular anatomy and physiology. We tested the hypothesis in sheep that maternal treatment with antioxidants protects against fetal growth restriction and programmed hypertension in adulthood in gestation complicated by chronic fetal hypoxia, the most common adverse consequence in human pregnancy. Using bespoke isobaric chambers, chronically catheterized sheep carrying singletons underwent normoxia or hypoxia (10% oxygen [O(2)]) ± vitamin C treatment (maternal 200 mg.kg(−1) IV daily) for the last third of gestation. In one cohort, the maternal arterial blood gas status, the value at which 50% of the maternal hemoglobin is saturated with oxygen (P(50)), nitric oxide (NO) bioavailability, oxidative stress, and antioxidant capacity were determined. In another, naturally delivered offspring were raised under normoxia until early adulthood (9 months). Lambs were chronically instrumented and cardiovascular function tested in vivo. Following euthanasia, femoral arterial segments were isolated and endothelial function determined by wire myography. Hypoxic pregnancy induced fetal growth restriction and fetal oxidative stress. At adulthood, it programmed hypertension by enhancing vasoconstrictor reactivity and impairing NO-independent endothelial function. Maternal vitamin C in hypoxic pregnancy improved transplacental oxygenation and enhanced fetal antioxidant capacity while increasing NO bioavailability, offsetting constrictor hyper-reactivity and replenishing endothelial function in the adult offspring. These discoveries provide novel insight into mechanisms and interventions against fetal growth restriction and adult-onset programmed hypertension in an animal model of complicated pregnancy in a species of similar temporal developmental milestones to humans. Public Library of Science 2019-01-22 /pmc/articles/PMC6342530/ /pubmed/30668572 http://dx.doi.org/10.1371/journal.pbio.2006552 Text en © 2019 Brain et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Brain, Kirsty L.
Allison, Beth J.
Niu, Youguo
Cross, Christine M.
Itani, Nozomi
Kane, Andrew D.
Herrera, Emilio A.
Skeffington, Katie L.
Botting, Kimberley J.
Giussani, Dino A.
Intervention against hypertension in the next generation programmed by developmental hypoxia
title Intervention against hypertension in the next generation programmed by developmental hypoxia
title_full Intervention against hypertension in the next generation programmed by developmental hypoxia
title_fullStr Intervention against hypertension in the next generation programmed by developmental hypoxia
title_full_unstemmed Intervention against hypertension in the next generation programmed by developmental hypoxia
title_short Intervention against hypertension in the next generation programmed by developmental hypoxia
title_sort intervention against hypertension in the next generation programmed by developmental hypoxia
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6342530/
https://www.ncbi.nlm.nih.gov/pubmed/30668572
http://dx.doi.org/10.1371/journal.pbio.2006552
work_keys_str_mv AT brainkirstyl interventionagainsthypertensioninthenextgenerationprogrammedbydevelopmentalhypoxia
AT allisonbethj interventionagainsthypertensioninthenextgenerationprogrammedbydevelopmentalhypoxia
AT niuyouguo interventionagainsthypertensioninthenextgenerationprogrammedbydevelopmentalhypoxia
AT crosschristinem interventionagainsthypertensioninthenextgenerationprogrammedbydevelopmentalhypoxia
AT itaninozomi interventionagainsthypertensioninthenextgenerationprogrammedbydevelopmentalhypoxia
AT kaneandrewd interventionagainsthypertensioninthenextgenerationprogrammedbydevelopmentalhypoxia
AT herreraemilioa interventionagainsthypertensioninthenextgenerationprogrammedbydevelopmentalhypoxia
AT skeffingtonkatiel interventionagainsthypertensioninthenextgenerationprogrammedbydevelopmentalhypoxia
AT bottingkimberleyj interventionagainsthypertensioninthenextgenerationprogrammedbydevelopmentalhypoxia
AT giussanidinoa interventionagainsthypertensioninthenextgenerationprogrammedbydevelopmentalhypoxia